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Abstract 
Linkage analysis studies have indicated that the chromosome band 14q24.3 harbours a major gene for familial early-onset Alz- 
heimer’s disease (AD). Recently we localized the chromosome 14 AD gene (AD3) in the 6.4 CM interval between the markers 
D14S289 and D14S61. We mapped the gene encoding dihydrolipoyl succinyltransferase (DLST), the E2k component of human a- 
ketoglutarate dehydrogenase complex (KGDHC), in the AD3 candidate region using yeast artificial chromosomes (YACs). The DLST 
gene is a candidate for the AD3 gene since deficiencies in KGDHC activity have been observed in brain tissue and fibroblasts of AD 
patients. The 15 exons and the promoter region of the DLST gene were analysed for mutations in chromosome 14 linked AD cases and 
in two series of unrelated early-onset AD cases (onset age < 55 years). Sequence variations in intro& sequences (introns 3, 5 and 10) 
or silent mutations in exonic sequences (exons 8 and 14) were identified. However, no AD related mutations were observed, suggesting 
that the DLST gene is not the chromosome 14 AD3 gene. 
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A genome-wide search has resulted in the localization 
of a gene for familial early-onset Alzheimer’s disease 
(AD) on chromosome 14q24.3 in an interval of 22.7 CM 
between the markers D14S52 and D14S.53 [19]. Chromo- 
some 14 linkage of early-onset AD was also found inde- 
pendently by three other groups [ 16,21,22]. Since these 
initial chromosome 14 linkage reports many other inves- 
tigators have reported linkage to chromosome 14 in their 
families [4,8,15,23], indicating that the chromosome 14 
gene is a major gene for familial early-onset AD. More 
recently, we were able to reduce substantially the size of 
the candidate region for the chromosome 14 AD gene 
(AD3) based on informative recombinants in the two 
* Corresponding author. Tel. +32 3 8202601; fax: +32 3 8202541. 
Belgian chromosome 14 linked early-onset AD families 
AD/A and AD/B [7]. The AD3 was localized between the 
markers D14S289 and D14S61, a region of 6.4 CM on the 
integrated genetic map of chromosome 14 [3]. Also, we 
constructed a physical map of the AD3 candidate region 
consisting of overlapping yeast artificial chromosomes 
(YACs) and estimated that the size of the AD3 candidate 
region is between 2 and 6 Mb [5,7]. The YAC contig map 
was used to map known genes that were previously as- 
signed to chromosome 14 using different mapping meth- 
ods. Three genes mapped within the AD3 candidate re- 
gion, i.e. the cellular oncogene c-fos (FOS), the trans- 
forming growth factor j33 gene (TGFB3) and the dihy- 
drolipoyl succinyltransferase gene (DLST) [5,7]. FOS has 
been excluded as the AD3 gene since sequence analyses 
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Table 1 
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Primer sequences used in the SSCP analysis and sequencing of DLST 
Region Primer Position Sequence Size 
Exon 1 
Exon 2 
Exon 3 
Exon 4 
Exon 5 
Exon 6 
Intron 6 
Exon 7 
Exon 8 
Exon 9 
Exon 10 
Exon 11 
Exon 12 
Exon 13 
Exon 14 
Exon 15 
E2k-3 
E2k-4 
E2k-52 
E2k-19 
E2k-20 
E2k-21 
E2k-22 
E2k-23 
E2k-24 
E2k-25 
E2k-26 
E2k-27 
E2k-30 
E2k-5 
E2k-6 
E2k-17 
E2k-18 
E2k-7 
E2k-8 
E2k-9 
E2k-10 
E2k-15 
E2k-16 
E2k-3 1 
E2k-32 
E2k-33 
E2k-34 
E2k-35 
E2k-36 
E2k-37 
E2k-38 
E2k-39 
E2k-40 
E2k-5 1 
E2k-11 
E2k-12 
E2k-13 
E2k-14 
-649 to -629 AGTTTGGCTGGAATTfGCGTT 
-188 to -210 GAGGTGGTTCTCCTGAAGGTGTA 
-645 to -627 TGGCTGGAATIXiCGTIGG 
-71 to -55 AGTGGTTCGCTCCGAAC 
151-135 AACAGACTCCTCACCCG 
543-565 GTTGCAl-l-TACITCGGAGTTACG 
852-83 1 CGTGATTATGTAGCATIGCGTC 
3540-3559 TATATCCGTTGCCGTTGATC 
3770-3744 CTTTATGTCT-l-TAAATAATAACCCGTG 
7116-7134 AAATGTGAGTGGTTCGCCT 
7395-7376 TGACAGATTCTGCAAACGCT 
7250-7273 TTTATGGGAAGAGCAACAA’lTGAT 
7494-7475 ACTCCAGGCTGGGAACAGAG 
7847-7870 CATATGTACTTTCTGCTGGCCCTG 
8066-8043 AAGCCCATGAAAAGCTGGTACGAA 
8669-8692 GAAGTGAATCTTCACAGCTAGCGA 
8875-8856 GGCAGGTGGAGCCATATCGT 
8995-9016 GTGATCCGCCTGCCTTGGCATC 
9292-9267 GAGGGAACACTGGAGACCTTGACCAC 
10793-10815 GCTGATACCCAGTAGACATTCGT 
11126-11102 CCT’lTGAAGGAACATAlTAGACGAG 
11327-11353 CTTGAAGATTAAGTAACAGTACATATG 
11592-11569 CATTCAAAGGTAGGCTACACCACA 
12293-12312 ATCTACTCGTGGCAAGCCGT 
12558-12537 ATAAGGAGTGGGGCAAG’ITCGT 
16360-16385 CACCTAACTTGTGTATATGGATTGAG 
16644-16622 GGAGCAGGTCTGTGCTCATACAC 
17939-17964 ATATTACCTCATTAGTCTTGGCCTTC 
18277-18252 CTAGAATACCTTCAT-TACTCAGTGTG 
18293-18317 GGTTGAATTCAAGGGAGTTGTTAAC 
18552-18530 ACTTGACTTTCCATGAGCACTGC 
19056-19071 TCGGCCTCCCAAAGCG 
19343-19319 CCACTAGGACCTTAGAAGTGACGGT 
19108-19132 GGGGTGGCTTAATA’ITTCAATTATG 
20134-20159 AATACTGTAAATATGCAGAGCGTAAC 
20388-20370 TCTGGGATCCT CTACCGCT 
20282-20300 TGCGGCCCATGATGTACGT 
20518-20496 ACAGCATGTGTCTGCCTGTCACC 
462 
(Sequencing primer) 
223 
310 
231 
280 
306 
220 
207 
296 
334 
266 
266 
285 
339 
260 
288 
(Sequencing primer) 
255 
237 
The position of the primers is according to the numbering of Nakano et al. [17] starting at exon 1. The size of the PCR products is indicated in bp. The 
PCR amplification of 200 ng genomic DNA was performed in a total volume of 25 ~1 according to standard procedures. The PCR sequencing was 
performed as described in the text. In case of the promoter region and exon 14, internal primers were designed for sequencing. 
did not reveal AD3 related mutations in patients belong- 
ing to different chromosome 14 linked early-onset AD 
families [2,6,18]. 
The DLST gene which codes for the E2k component 
of the mitochondrial a-ketoglutarate dehydrogenase 
complex (KGDHC), is a candidate for the AD3 gene be- 
cause reductions in KGDHC activity have been observed 
in AD patients. KGDHC is a multicomponent mitochon- 
drial enzyme complex that catalyses the rate-limiting step 
of oxidative decarboxylation of a-ketoglutarate to succi- 
nyl-CoA in the tricarboxylic acid cycle. A defect of this 
enzyme complex could explain the energy metabolism 
defects observed in brain and fibroblasts of AD patients 
[ 13,201. In AD brain the neuronal degeneration may be 
explained by excitotoxicity of glutamate, a brain neuro- 
toxin accumulating because of the KGDHC deficiency 
[ 131. In cultured fibroblasts of both AD and chromosome 
14 linked AD patients, immunoblotting identified an ab- 
normality of the E2k component of KGHDC [20]. The 
DLST gene coding for E2k, was cloned and mapped to 
chromosome 14q24.3 by somatic cell hybrid mapping and 
in situ hybridisation [l]. We used the YAC contig map to 
localize the DLST gene in the AD3 candidate region be- 
tween the linked markers D14S43 and D14S284 [5,7]. 
In this study we performed a mutation analysis of the 
DLST gene in patients with proven chromosome 14 
linked AD and in patients belonging to two series of unre- 
lated AD cases with onset of AD below or at age 
55 years. The cut-off age of 55 years was chosen because 
in the majority of the chromosome 14 linked families the 
h4. Guts et al. I Neuroscience Letters 199 (1995) 73-77 15 
mean age at onset is before this age [9]. The AD patients 
with chromosome 14 linked AD are AD/A-V43 and 
AD/B-IV15 belonging to families AD/A and AD/B [22], 
and two patients of each family FADl, FAD2 and FAD4 
[21], namely AG7647A, AG6849A, AG8526, AG8562A, 
AG8109A and AG7877 of which cell lines were obtained 
through the NIA cell repository. The two series of early- 
onset AD patients contained 21 patients with a mean on- 
set age of 50.2 +- 1.9 years (range 47-55 years) obtained 
in a population-based study of early-onset AD in the area 
of Rotterdam, The Netherlands [ 111, and 20 patients with 
mean onset age of 51.2 f 3.3 years (range 45-55 years) 
clinically ascertained at the University Hospital in Umei, 
Sweden (Adolfsson et al., unpublished data). Each of the 
patients received a diagnosis of presenile dementia that 
fulfilled the NINCDS-ADRDA criteria of probable AD 
[ 141. Also, mutation analysis of exons 16 and 17 of the 
amyloid precursor protein (APP) gene at chromosome 
21q21.2, using both single stranded conformational 
polymorphism (SSCP) analysis and direct PCR sequenc- 
ing had not revealed any mutations in these patients ([24]; 
Adolfsson et al., unpublished data). 
First we examined all 15 exons of the DLST gene for 
mutations by SSCP analysis. For this purpose intronic 
primers flanking each exon were designed based on the 
published genomic sequence of the DLST gene [ 171. For 
the larger exon 15, two overlapping primer sets were 
used. The sequences of each primer pair used in the SSCP 
analysis are illustrated in Table 1. Each exon was PCR 
amplified under standard conditions and the PCR prod- 
ucts were heat denatured and separated by electrophoresis 
at room temperature on a 1 X Hydrolink MDE gel (J.T. 
Baker, Phillipsburg, USA) in the presence or absence of 
10% glycerol. The electrophoresis conditions of 13 h at 
800 V allowed the analysis in one experiment of both the 
heteroduplex and SSCP. The DNA fragments were visual- 
ized by silver-staining [lo]. Clearly altered SSCP patterns 
were detected when exons 5 and 11 were analysed in the 
presence of glycerol and exons 8 and 14 in the absence of 
glycerol. The change in the SSCP pattern of exons 5, 8, 
11 and 14 was the same in each case, suggesting that the 
same sequence variation was present. Further, the altered 
SSCP patterns of exons 5, 8, 11 and 14 were present in 
some but not all of the chromosome 14 linked AD and 
early-onset AD patients. Also, since for each of the exons 
5, 8, 11 and 14, homozygotes were detected for each 
SSCP allele, the data suggested that the sequence varia- 
tions in these exons are polymorphisms and not AD re- 
lated mutations. No polymorphic variations were detected 
for the (GTT)s repeat located in intron 6 [17], when 
genomic DNA of the 49 AD patients was PCR amplified 
using primers E2k- 17 and E2k-18 (Table 1). 
The sequences of exons 5, 8, 11 and 14 were deter- 
mined after PCR amplification of genomic DNA of pa- 
tients AD/A-V43 and AD/B-IVl5, and one escapee, 
AD/A-V30 and AD/B-IVS, of each of the two Belgian 
Table 2 
DLST polymorphisms 
Primers 
E2k-25, 
E2k-26 
E2k-27, 
E2k-30 
E2k-9, 
E2k-10 
E2k-3 1, 
E2k-32 
E2k-39, 
E2k-40 
Location of 
polymorphism 
lntron 3 
Intron 5 
Exon 8 
lntron 10 
Exon 14 
Nucleotide Type of 
position polymorphism 
7160 C insertion 
7461 CT), repeat 
11044 G to A transition 
16439 G to A transition 
19183 C to T transition 
The position of the polymorphisms is according to the numbering of 
Nakano et al. [ 171 starting at exon 1. 
chromosome 14 linked families AD/A and AD/B [ 121. An 
escapee was defined as a healthy individual of whom the 
current age was at least two standard deviations beyond 
the mean age at onset of 35 years in the family. For se- 
quencing, the PCR products of six identical PCR reac- 
tions were pooled and the PCR products were purified by 
the Spinbind Purification System of FMC (Rockland, 
USA). The sequences of both strands were determined 
with the fluorescent T7 terminator system of Applied 
Biosystems (Foster City, USA) and were analysed on an 
automated DNA sequencer model 373A of Applied Bio- 
systems (Foster City, USA). In each case a mutation was 
found that could explain the altered bands in the SSCP 
analysis (Table 2). Two of the mutations are intronic se- 
quence variations, a diallelic (T),-repeat in intron 5 and a 
transition of A to G in intron 10. The mutations in exons 
8 and 14 are silent mutations at third codon bases at 
codons 192 and 366, respectively. None of the mutations 
were AD specific since they were found in both the AD 
patients and escapees, confirming our previous observa- 
tion that the altered SSCP patterns represent DLST poly- 
morphisms. The allele frequencies for each DLST poly- 
morphism were calculated from the SSCP results obtained 
in the whole population of 49 AD patients and were 
0.57/0.43 for the intron 5 polymorphism, 0.81/O. 19 for 
the exon 8 polymorphism, 0.46iO.54 for the intron 10 
polymorphism and 0.44/0.56 for the exon 14 polymor- 
phism. 
Linkage analysis in families AD/A and AD/B using the 
exon 14 DLST polymorphism showed complete segrega- 
tion of DLST with AD. Consequently we sequenced all 
other 11 exons and the promoter region of DLST (Table 
1). No AD related sequence differences were observed. 
However, one more polymorphism was detected in intron 
3 where a C insertion was observed in patient AD/A-V43 
and escapee AD/B-IV5 (Table 2). 
In conclusion, the mutation analysis of DLST in chro- 
mosome 14 linked AD patients and patients with early- 
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onset of AD before or at age 55 years has not revealed 
mutations that are AD related. In total, five polymorphic 
sequence variations were detected, three in, respectively, 
introns 3, 5 and 10, and two in, respectively, exons 8 and 
14. The latter two polymorphisms, although in coding 
sequences, do not cause a change at the protein level 
since they are both silent mutations at third codon bases. 
The absence of AD related mutations in the coding region 
and the promoter of DLST excludes this gene as candi- 
date for AD3. 
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